Pfizer-BioNTech to seek authorization for 3rd Covid shot

Pfizer and BioNTech announced Thursday they would seek authorization for a third dose of their Covid-19 vaccine to boost its efficacy, as the Delta variant drove devastating outbreaks in Asia and Africa and cases rose again in Europe and the United States. Lecturer in Infectious Disease Epidemiology Marc Paguelin tells us more.